Dedication
In memory of Henrietta, June 20th, 2022 to February 22nd, 2026. In life, Henrietta reminded us that to be loved, safe, and free from pain is the greatest gift that can be given. In her passing, her triumph despite the odds may help extend the lives of many hens.
Abstract
Reproductive tract disease is common in modern laying hens, particularly in high-production breeds selected for sustained egg output. Ovarian adenocarcinoma has been reported in up to 30–35% of domestic hens, and other ovulation-associated disorders including egg yolk peritonitis and salpingitis have been reported in 20-30% of domestic hens. As increasing numbers of hens are maintained as companion animals beyond commercial culling age, the clinical consequences of sustained ovulatory demand are becoming more visible.
This report describes the clinical course of a Black Australorp hen diagnosed with advanced intra-coelomic reproductive disease at 2 years and 8 months of age. Radiographs demonstrated a large intra-coelomic mass with significant organ displacement. Initial prognosis was approximately one month survival. Following diagnosis, endocrine suppression therapy was initiated using leuprolide acetate followed by Deslorelin implantation. Hormonal management resulted in improved appetite, activity, and sustained quality of life despite advanced disease.
The hen survived approximately eleven months beyond initial prognosis with preserved functional behavior until sudden death. This case highlights both the potential welfare benefits of endocrine suppression and the broader biologic consequences of sustained ovulatory intensity in modern production breeds.
Keywords
Laying hen
Ovarian cancer
Salpingitis
Reproductive disease
High production hens
Deslorelin implant
GnRH agonist
Egg yolk peritonitis
Anti inflammatory medication for chickens
Ovulation suppression
Introduction
Selective breeding has transformed the domestic hen into one of the most productive egg-laying animals in agriculture. The wild junglefowl lays 10-15 egg per year while modern production hens lay 250–320 eggs annually, far exceeding the seasonal reproductive patterns of their ancestral counterparts. This means their reproductive system is pushed 20-30 times beyond natural evolution, greatly increasing risk of ovarian cancer, salpingitis, and egg yolk peritonitis. This sustained ovulatory intensity has successfully increased output; however, it has also coincided with a substantial rise in reproductive tract pathology. Figure 4.
Necropsy surveys demonstrate overall reproductive disease in approximately 30–60% of laying hens over their lifetime. Ovarian adenocarcinoma has been reported in up to 30–35% of high-production populations (Fredrickson, 1987), a prevalence sufficiently high that the domestic hen has become a principal spontaneous animal model for human ovarian cancer research. Egg yolk peritonitis and salpingitis are similarly common, affecting approximately 20–40% and 15–35% of adult hens, respectively, with higher rates observed in extended-lay and high-production strains.
Each ovulation event involves follicular rupture, localized inflammation, and subsequent tissue repair under sustained estrogen and progesterone influence. In high-production hens, several hundred ovulatory cycles may occur within the first few years of life. Cumulative reproductive tissue stress associated with this “incessant ovulation” is considered a primary driver of ovarian neoplasia and other ovulation-associated disorders.
As increasing numbers of production-breed hens are maintained beyond commercial culling age in backyard and companion settings, the long-term consequences of sustained ovulation are becoming more apparent. The following case illustrates both the biologic burden of reproductive disease and the potential impact of endocrine suppression in altering disease trajectory.
Case Presentation
Henrietta, a Black Australorp hen, was hatched on June 20, 2022. Prior to illness she weighed 9.1 pounds and lived as a companion backyard hen.
In February 2025 Henrietta developed progressive difficulty climbing stairs to the coop. She had stopped laying eggs, and had generalized weakness. Veterinary evaluation was performed on March 6, 2025. Physical examination and radiographs identified a large intra-coelomic mass estimated to be the size of a large orange. The initial diagnosis provided was a coelomic neoplasm and she was given approximately one month survival. She was prescribed meloxicam.
Euthanasia was scheduled for March 20, 2025; however, the decision was deferred after arriving at the veterinary office due to the caretakers conclusion that she was still actively engaged with her environment and had preserved appetite.
Further research suggested the possibility of hormonally driven reproductive pathology. Endocrine suppression was initiated using leuprolide acetate. Induction therapy consisted of 4- injections administered approximately two to three weeks apart, followed by monthly maintenance therapy.
Subsequently, a 4.7mg Deslorelin implant was placed on August 26, 2025 to provide longer-term ovulation suppression. A replacement Deslorelin implant was place on 11/1/2025, and a third on 1/15/2026.
Henrietta’s Photographs
Henrietta, the Black Australorp hen described in this report, photographed during the course of her illness. Despite advanced reproductive cancer, she maintained normal behavior and engagement with her environment for an period following hormonal suppression therapy.
From left to right: Henrietta March 20th, 2025, the day she was to scheduled to be euthanized, Henrietta July 2025, Henrietta October 2025, Henrietta February 5, 2026.
Clinical Course
At the time of diagnosis, Henrietta exhibited signs consistent with significant intra-coelomic disease including altered posture during defecation and asymmetry in limb diameter. The diameter of the right leg was significantly larger than the left, likely reflecting pressure effects from the coelomic mass.
These early clinical signs, particularly altered defecation posture and asymmetric limb swelling, are consistent with mass effect from intra-coelomic reproductive disease and may represent early indicators of reproductive pathology in companion hens.
Following endocrine suppression therapy and implantation, Henrietta demonstrated notable clinical improvement. Appetite increased, activity levels improved, and behavioral engagement with her environment returned. Henrietta also received Meloxicam everyday to manage inflammation.
Expected physiologic signs of ovulation suppression occurred following implantation, including comb lightening and molting. Egg laying had ceased approximately one month prior to diagnosis and did not resume.
In late October 2025 subtle behavioral changes were observed including mild agitation and comb color change, raising concern for declining hormonal suppression. The implant was replaced at 88 days rather than the planned 100-day interval.
Following re-implantation, Henrietta returned to stable behavior and maintained normal appetite and activity.
Henrietta continued to live with preserved quality of life, going outside with the flock 1-2 hours a day, eating normally and even jumping to roosts until February 22, 2026, when she died suddenly at approximately 8:11 AM. She had been eating and drinking normally until the time of death. Figure 3
Supportive Care and Environmental Management
In addition to endocrine therapy, extensive supportive care is required to maintain comfort and functional quality of life. Due to the size and position of the intra-coelomic mass, environmental and physical accommodations were necessary throughout the course of disease management.
Henrietta was housed indoors for the majority of her illness in order to maintain stable environmental conditions. Temperature control was particularly important, as hens with significant coelomic disease may have reduced tolerance for environmental stressors. Indoor housing allowed close monitoring of behavior, appetite, and mobility while minimizing energy expenditure associated with thermoregulation.
Because the abdominal mass created pressure within the coelomic cavity, soft and supportive resting surfaces were provided. Thick, padded bedding was used to reduce pressure on the abdomen and allow comfortable recumbency.
Outdoor access was maintained in a controlled manner to preserve normal behavioral enrichment. Henrietta was allowed approximately one to two hours of supervised outdoor time daily when weather conditions permitted.
Close daily observation was essential throughout the course of care. Appetite, posture, behavior, mobility, and droppings were monitored regularly.
Social Support and Flock Stability
In addition to environmental and physical accommodations, maintenance of a stable social companion appeared to play an important role in Henrietta’s overall well-being. Henrietta lived continuously with a companion hen, Ava, who remained with her both indoors and during supervised outdoor time.
Chickens are highly social, and disruption of established flock relationships can lead to behavioral distress. Maintaining this constant companionship appeared to support normal social behavior and reduce signs of agitation or isolation that might otherwise occur during prolonged illness. While the physiologic effects of social stability are difficult to quantify, preserving a familiar flockmate likely contributed positively to overall welfare during the course of disease management.
Radiographic Findings
Whole-body radiographs obtained March 6, 2025 demonstrated marked enlargement of the caudal coelomic cavity characterized by a large, poorly defined soft-tissue opacity occupying much of the abdominal space. Normal organ margins were obscured due to mass effect. The x-rays were interpreted by a board certified small animal radiologist.
The caudal body contour was expanded and rounded, and intestinal structures appeared displaced from expected anatomic positions. Air sac definition was reduced, suggesting cranial compression by the mass.
Clustered mineral-opaque material was present near the pelvic region, consistent with retained reproductive material. These findings supported a reproductive tract origin of the intra-coelomic mass. Figures 1,2
Post ovulation suppression x-rays were not necessary. When a tumor is hormonally driven as was Henrietta’s, ovulation suppression will only slow growth, not reduce tumor size.
This case demonstrates that advanced reproductive pathology in laying hens may be hormonally modulated even after substantial structural disease has developed. Endocrine suppression as well as supportive care successfully stabilized biologic progression and preserved functional quality of life for an extended period despite radiographic evidence of advanced intra-coelomic neoplasia at diagnosis.
The extended survival observed in this case likely reflects not only endocrine suppression but also intensive supportive husbandry including environmental control, padded resting surfaces, and continuous monitoring.
However, treatment addresses downstream consequences rather than upstream causes. Sustained ovulatory intensity remains the central biologic driver of reproductive tract disease in modern laying hens. Repeated follicular rupture, chronic inflammatory cycling, and prolonged hormone exposure create conditions conducive to ovarian neoplasia, egg yolk peritonitis, and salpingitis.
When hens are allowed to live beyond peak commercial production cycles, the cumulative burden of this ovulatory stress becomes increasingly evident.
While endocrine intervention may extend quality of life once disease manifests, prevention operates earlier in the causal chain. Given the established relationship between ovulation frequency and reproductive pathology, breed selection represents a primary upstream determinant of long-term health outcomes in domestic hens. Awareness of this association allows prospective keepers to make informed decisions regarding productivity versus longevity, particularly when hens are intended as long-term companions rather than short-cycle production animals.
Henrietta’s clinical course highlights both the therapeutic potential of hormonal management and the predictable biologic consequences of sustained ovulatory demand. Her case underscores the importance of early recognition, informed management, and thoughtful breed selection in shaping lifetime welfare outcomes.
Conclusion
Henrietta’s case illustrates that endocrine suppression may significantly extend quality of life in hens with hormonally responsive reproductive disease. However, the high prevalence of ovulation-associated pathology in modern production breeds suggests that long-term prevention may depend primarily on informed breed selection and reproductive management.
Every day Henrietta lived against great odds; she brought hope and love to everyone around her. In her passing, she continues to give hope to the many hens who face this tragic disease.
Figure Captions
Figure 1.
Lateral radiograph obtained at the time of diagnosis demonstrating marked enlargement of the caudal coelomic cavity with a large soft-tissue opacity consistent with an intra-coelomic reproductive mass.
Figure 2.
Additional radiographic projection illustrating the extent of the coelomic mass and associated organ displacement within the abdominal cavity.
Figure 3.
Clinical timeline of Henrietta’s disease course, including diagnosis, endocrine suppression therapy, deslorelin implantation, and maintained quality of life prior to death.
Figure 4.
References
Fredrickson TN. 1987. Ovarian tumors of the hen. Environmental Health Perspectives.
Johnson PA, Giles JR. The laying hen as a model for ovarian cancer.
Swayne DE et al. Diseases of Poultry.
Speer BL. Avian Medicine and Surgery.
Fathalla MF. Incessant ovulation and ovarian cancer hypothesis.
Johnson, P.A., C.S. Stephens, and J.R. Giles. The domestic chicken: causes and consequences of an egg a day. Poultry Science 94.4 (2015)
In memory of Henrietta, June 20th, 2022 to February 22nd, 2026. In life, Henrietta reminded us that to be loved, safe, and free from pain is the greatest gift that can be given. In her passing, her triumph despite the odds may help extend the lives of many hens.
Reproductive tract disease is common in modern laying hens, particularly in high-production breeds selected for sustained egg output. Ovarian adenocarcinoma has been reported in up to 30–35% of domestic hens, and other ovulation-associated disorders including egg yolk peritonitis and salpingitis have been reported in 20-30% of domestic hens. As increasing numbers of hens are maintained as companion animals beyond commercial culling age, the clinical consequences of sustained ovulatory demand are becoming more visible.
This report describes the clinical course of a Black Australorp hen diagnosed with advanced intra-coelomic reproductive disease at 2 years and 8 months of age. Radiographs demonstrated a large intra-coelomic mass with significant organ displacement. Initial prognosis was approximately one month survival. Following diagnosis, endocrine suppression therapy was initiated using leuprolide acetate followed by Deslorelin implantation. Hormonal management resulted in improved appetite, activity, and sustained quality of life despite advanced disease.
The hen survived approximately eleven months beyond initial prognosis with preserved functional behavior until sudden death. This case highlights both the potential welfare benefits of endocrine suppression and the broader biologic consequences of sustained ovulatory intensity in modern production breeds.
Laying hen
Ovarian cancer
Salpingitis
Reproductive disease
High production hens
Deslorelin implant
GnRH agonist
Egg yolk peritonitis
Anti inflammatory medication for chickens
Ovulation suppression
Selective breeding has transformed the domestic hen into one of the most productive egg-laying animals in agriculture. The wild junglefowl lays 10-15 egg per year while modern production hens lay 250–320 eggs annually, far exceeding the seasonal reproductive patterns of their ancestral counterparts. This means their reproductive system is pushed 20-30 times beyond natural evolution, greatly increasing risk of ovarian cancer, salpingitis, and egg yolk peritonitis. This sustained ovulatory intensity has successfully increased output; however, it has also coincided with a substantial rise in reproductive tract pathology. Figure 4.
Necropsy surveys demonstrate overall reproductive disease in approximately 30–60% of laying hens over their lifetime. Ovarian adenocarcinoma has been reported in up to 30–35% of high-production populations (Fredrickson, 1987), a prevalence sufficiently high that the domestic hen has become a principal spontaneous animal model for human ovarian cancer research. Egg yolk peritonitis and salpingitis are similarly common, affecting approximately 20–40% and 15–35% of adult hens, respectively, with higher rates observed in extended-lay and high-production strains.
Each ovulation event involves follicular rupture, localized inflammation, and subsequent tissue repair under sustained estrogen and progesterone influence. In high-production hens, several hundred ovulatory cycles may occur within the first few years of life. Cumulative reproductive tissue stress associated with this “incessant ovulation” is considered a primary driver of ovarian neoplasia and other ovulation-associated disorders.
As increasing numbers of production-breed hens are maintained beyond commercial culling age in backyard and companion settings, the long-term consequences of sustained ovulation are becoming more apparent. The following case illustrates both the biologic burden of reproductive disease and the potential impact of endocrine suppression in altering disease trajectory.
Case Presentation
Henrietta, a Black Australorp hen, was hatched on June 20, 2022. Prior to illness she weighed 9.1 pounds and lived as a companion backyard hen.
In February 2025 Henrietta developed progressive difficulty climbing stairs to the coop. She had stopped laying eggs, and had generalized weakness. Veterinary evaluation was performed on March 6, 2025. Physical examination and radiographs identified a large intra-coelomic mass estimated to be the size of a large orange. The initial diagnosis provided was a coelomic neoplasm and she was given approximately one month survival. She was prescribed meloxicam.
Euthanasia was scheduled for March 20, 2025; however, the decision was deferred after arriving at the veterinary office due to the caretakers conclusion that she was still actively engaged with her environment and had preserved appetite.
Further research suggested the possibility of hormonally driven reproductive pathology. Endocrine suppression was initiated using leuprolide acetate. Induction therapy consisted of 4- injections administered approximately two to three weeks apart, followed by monthly maintenance therapy.
Subsequently, a 4.7mg Deslorelin implant was placed on August 26, 2025 to provide longer-term ovulation suppression. A replacement Deslorelin implant was place on 11/1/2025, and a third on 1/15/2026.
Henrietta’s Photographs
Henrietta, the Black Australorp hen described in this report, photographed during the course of her illness. Despite advanced reproductive cancer, she maintained normal behavior and engagement with her environment for an period following hormonal suppression therapy.
From left to right: Henrietta March 20th, 2025, the day she was to scheduled to be euthanized, Henrietta July 2025, Henrietta October 2025, Henrietta February 5, 2026.
Clinical Course
At the time of diagnosis, Henrietta exhibited signs consistent with significant intra-coelomic disease including altered posture during defecation and asymmetry in limb diameter. The diameter of the right leg was significantly larger than the left, likely reflecting pressure effects from the coelomic mass.
These early clinical signs, particularly altered defecation posture and asymmetric limb swelling, are consistent with mass effect from intra-coelomic reproductive disease and may represent early indicators of reproductive pathology in companion hens.
Following endocrine suppression therapy and implantation, Henrietta demonstrated notable clinical improvement. Appetite increased, activity levels improved, and behavioral engagement with her environment returned. Henrietta also received Meloxicam everyday to manage inflammation.
Expected physiologic signs of ovulation suppression occurred following implantation, including comb lightening and molting. Egg laying had ceased approximately one month prior to diagnosis and did not resume.
In late October 2025 subtle behavioral changes were observed including mild agitation and comb color change, raising concern for declining hormonal suppression. The implant was replaced at 88 days rather than the planned 100-day interval.
Following re-implantation, Henrietta returned to stable behavior and maintained normal appetite and activity.
Henrietta continued to live with preserved quality of life, going outside with the flock 1-2 hours a day, eating normally and even jumping to roosts until February 22, 2026, when she died suddenly at approximately 8:11 AM. She had been eating and drinking normally until the time of death. Figure 3
Supportive Care and Environmental Management
In addition to endocrine therapy, extensive supportive care is required to maintain comfort and functional quality of life. Due to the size and position of the intra-coelomic mass, environmental and physical accommodations were necessary throughout the course of disease management.
Henrietta was housed indoors for the majority of her illness in order to maintain stable environmental conditions. Temperature control was particularly important, as hens with significant coelomic disease may have reduced tolerance for environmental stressors. Indoor housing allowed close monitoring of behavior, appetite, and mobility while minimizing energy expenditure associated with thermoregulation.
Because the abdominal mass created pressure within the coelomic cavity, soft and supportive resting surfaces were provided. Thick, padded bedding was used to reduce pressure on the abdomen and allow comfortable recumbency.
Outdoor access was maintained in a controlled manner to preserve normal behavioral enrichment. Henrietta was allowed approximately one to two hours of supervised outdoor time daily when weather conditions permitted.
Close daily observation was essential throughout the course of care. Appetite, posture, behavior, mobility, and droppings were monitored regularly.
In addition to environmental and physical accommodations, maintenance of a stable social companion appeared to play an important role in Henrietta’s overall well-being. Henrietta lived continuously with a companion hen, Ava, who remained with her both indoors and during supervised outdoor time.
Chickens are highly social, and disruption of established flock relationships can lead to behavioral distress. Maintaining this constant companionship appeared to support normal social behavior and reduce signs of agitation or isolation that might otherwise occur during prolonged illness. While the physiologic effects of social stability are difficult to quantify, preserving a familiar flockmate likely contributed positively to overall welfare during the course of disease management.
Radiographic Findings
Whole-body radiographs obtained March 6, 2025 demonstrated marked enlargement of the caudal coelomic cavity characterized by a large, poorly defined soft-tissue opacity occupying much of the abdominal space. Normal organ margins were obscured due to mass effect. The x-rays were interpreted by a board certified small animal radiologist.
The caudal body contour was expanded and rounded, and intestinal structures appeared displaced from expected anatomic positions. Air sac definition was reduced, suggesting cranial compression by the mass.
Clustered mineral-opaque material was present near the pelvic region, consistent with retained reproductive material. These findings supported a reproductive tract origin of the intra-coelomic mass. Figures 1,2
Post ovulation suppression x-rays were not necessary. When a tumor is hormonally driven as was Henrietta’s, ovulation suppression will only slow growth, not reduce tumor size.
DiscussionThis case demonstrates that advanced reproductive pathology in laying hens may be hormonally modulated even after substantial structural disease has developed. Endocrine suppression as well as supportive care successfully stabilized biologic progression and preserved functional quality of life for an extended period despite radiographic evidence of advanced intra-coelomic neoplasia at diagnosis.
The extended survival observed in this case likely reflects not only endocrine suppression but also intensive supportive husbandry including environmental control, padded resting surfaces, and continuous monitoring.
However, treatment addresses downstream consequences rather than upstream causes. Sustained ovulatory intensity remains the central biologic driver of reproductive tract disease in modern laying hens. Repeated follicular rupture, chronic inflammatory cycling, and prolonged hormone exposure create conditions conducive to ovarian neoplasia, egg yolk peritonitis, and salpingitis.
When hens are allowed to live beyond peak commercial production cycles, the cumulative burden of this ovulatory stress becomes increasingly evident.
While endocrine intervention may extend quality of life once disease manifests, prevention operates earlier in the causal chain. Given the established relationship between ovulation frequency and reproductive pathology, breed selection represents a primary upstream determinant of long-term health outcomes in domestic hens. Awareness of this association allows prospective keepers to make informed decisions regarding productivity versus longevity, particularly when hens are intended as long-term companions rather than short-cycle production animals.
Henrietta’s clinical course highlights both the therapeutic potential of hormonal management and the predictable biologic consequences of sustained ovulatory demand. Her case underscores the importance of early recognition, informed management, and thoughtful breed selection in shaping lifetime welfare outcomes.
Henrietta’s case illustrates that endocrine suppression may significantly extend quality of life in hens with hormonally responsive reproductive disease. However, the high prevalence of ovulation-associated pathology in modern production breeds suggests that long-term prevention may depend primarily on informed breed selection and reproductive management.
Figure Captions
Figure 1.
Lateral radiograph obtained at the time of diagnosis demonstrating marked enlargement of the caudal coelomic cavity with a large soft-tissue opacity consistent with an intra-coelomic reproductive mass.
Figure 2.
Additional radiographic projection illustrating the extent of the coelomic mass and associated organ displacement within the abdominal cavity.
Figure 3.
Clinical timeline of Henrietta’s disease course, including diagnosis, endocrine suppression therapy, deslorelin implantation, and maintained quality of life prior to death.
June 20, 2022 | Henrietta hatched (Black Australorp). |
Early February 2025 | First clinical sign noted: difficulty climbing stairs to coop. |
March 6, 2025 | Veterinary examination and radiographs reveal large intra-coelomic mass estimated to be grapefruit-sized. Prognosis approximately one month survival. |
March 20, 2025 | Euthanasia appointment scheduled but deferred due to preserved appetite, behavior, and engagement with environment. |
Spring/Summer 2025 | Hormonal suppression initiated using Leuprolide injections (four induction doses administered approximately 2-3 weeks apart). |
August 26, 2025 | First Deslorelin implant placed for long-term ovulation suppression. |
Post-implant period | Clinical improvement noted including increased appetite, improved activity, comb lightening, and molt consistent with ovulation suppression. |
Mid-November 2025 | Subtle behavioral changes noted including agitation and comb color change, suggesting declining hormonal suppression. |
November 2025 (Day 88) | Second deslorelin implant placed earlier than scheduled (original plan:100 days). Clinical stability returns. |
January 2026 | Third Deslorelin implant placed also earlier than typically scheduled |
February 22, 2026 | Henrietta passes suddenly at approximately 8:11 AM after maintaining normal appetite and behavior until the time of death. |
Total survival after diagnosis | Approximately 11 months, significantly exceeding initial prognosis of one month. |
Fredrickson TN. 1987. Ovarian tumors of the hen. Environmental Health Perspectives.
Johnson PA, Giles JR. The laying hen as a model for ovarian cancer.
Swayne DE et al. Diseases of Poultry.
Speer BL. Avian Medicine and Surgery.
Fathalla MF. Incessant ovulation and ovarian cancer hypothesis.
Johnson, P.A., C.S. Stephens, and J.R. Giles. The domestic chicken: causes and consequences of an egg a day. Poultry Science 94.4 (2015)
